EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel therapeutic target for diabetic kidney disease through downregulation of miRNA-192-5p and miRNA-21-5p by celastrol: implication of autophagy, oxidative stress, and fibrosis

Samar M Al-Tantawy, Salma M Eraky, Laila A Eissa

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03669-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Samar M Al-Tantawy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. Hauptthemen laut MEDLINE: MicroRNAs, Pentacyclic Triterpenes, Diabetic Nephropathies, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mansoura University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the most common microvascular effects of diabetes mellitus (DM) that may result in end-stage renal failure is diabetic kidney disease (DKD). Current treatments carry a substantial residual risk of disease progression regardless of treatment. By modulating various molecular targets, pentacyclic triterpenoid celastrol has been found to possess curative properties in the treatment of diabetes and other inflammatory diseases. Therefore, the present study investigated whether celastrol has anti-inflammatory, antioxidant, and antifibrotic effects as a natural compound against experimental DKD. Streptozotocin (55 mg/kg) was utilized for inducing DKD in a rat model. Antioxidant enzymes and renal function tests were assessed in serum samples. In kidney homogenate, relative miRNA-192-5p and miRNA-21-5p gene expressions were measured. Furthermore, using real-time PCR to evaluate the gene expressions of nucleus erythroid 2–related factor-2 (Nrf-2), matrix metalloproteinase-2 (MMP-2), proapoptotic caspase-3, antiapoptotic Bcl-2, LC-3, and Beclin-1. Moreover, the transforming growth factor β1 (TGF-β1), LC-3, Bcl-2, caspase-3 and NADPH oxidase 4 (NOX4) renal expressions were assessed semi-quantitatively using immunohistochemistry. Seven weeks of celastrol (1.5 mg/kg/day) treatment significantly ameliorated DKD. Celastrol improves kidney functions. Moreover, celastrol treatment demonstrated potent antioxidant effect. The mechanism of apoptosis resulting from the administration of celastrol included the modulation of Bcl-2 and caspase-3 expression in the kidney. Celasterol administration leads to an increase in LC-3 and Beclin-1 renal expression that resulting in autophagy. Celastrol treatment improved renal fibrosis by decreasing TGF-β1 and MMP-2 renal expression. These antifibrotic effects could be due to their ability to inhibit miRNA-192-5p and miRNA-21-5p expression in renal tissues. Celastrol exerts a renoprotective effect by targeting miRNA-21 and miRNA-192, as well as their downstream pathways, such as autophagy, apoptosis, and fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPentacyclic TriterpenesDiabetic NephropathiesDiabetes Mellitus, ExperimentalTriterpenesAnimalsAutophagyOxidative StressMaleFibrosisDown-RegulationRatsKidneyAntioxidantsRats, Sprague-DawleyAnti-Inflammatory AgentsApoptosisStreptozocin

Stichwörter der Autor:innen

CelastrolDiabetic kidney diseaseMiRNA-192-5pMiRNA-21-5pTGF-β1Transforming growth factor β1

Substanzen

MicroRNAsPentacyclic Triterpenescelastrolmirn21 microRNA, ratAntioxidantsTriterpenesAnti-Inflammatory AgentsStreptozocin

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. salmamossad@mans.edu.eg.

Förderung

  • Mansoura University

Zitieren

APA

Al-Tantawy, S. M., Eraky, S. M., & Eissa, L. A. (2025). Novel therapeutic target for diabetic kidney disease through downregulation of miRNA-192-5p and miRNA-21-5p by celastrol: implication of autophagy, oxidative stress, and fibrosis. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03669-5

Vancouver

Al-Tantawy SM, Eraky SM, Eissa LA. Novel therapeutic target for diabetic kidney disease through downregulation of miRNA-192-5p and miRNA-21-5p by celastrol: implication of autophagy, oxidative stress, and fibrosis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03669-5

BibTeX
@article{AlTantawy2025,
  author = {Al-Tantawy, Samar M and Eraky, Salma M and Eissa, Laila A},
  title = {Novel therapeutic target for diabetic kidney disease through downregulation of miRNA-192-5p and miRNA-21-5p by celastrol: implication of autophagy, oxidative stress, and fibrosis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03669-5}
}
Kostenlos starten →